Feasibility study of a mobile device for the prevention of sepsis in patients with solid tumors after chemotherapy and patients with infectiose diseases (COVID-19)
Recruiting
- Conditions
- C00Coronavirus, COVID-19, U07.1!C00-C75U07.1Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissueCOVID-19, virus identified
- Registration Number
- DRKS00017593
- Lead Sponsor
- niklinik Frankfurt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with solid tumors and planned chemotherapy or patients with infections desease and risk for sepsis.
Exclusion Criteria
younger than 18 years
older than 99 years
Not able to sign informed consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pilot study on the feasibility and application of a mobile device on two patient collectives with risk for developing a sepsis. There is no primary endpoint because it is a pilot study.
- Secondary Outcome Measures
Name Time Method Sepsis prevention